Press Statement By EU Commission President von der Leyen On CureVac

BRUSSELS, BELGIUM - NOVEMBER 16: European Commission president Ursula von der Leyen gives a virtual press conference in the Berlaymont, the European headquarters on November 16, 2020, in Brussels, Belgium. The European Commission has agreed to purchase up to 405 million doses of a coronavirus vaccine candidate created by the German biotech company CureVac, President Ursula von der Leyen announced today, saying "We do not know which vaccine will end up being safe and effective. The European Medicines Agency will authorize them only after a robust assessment, and this is why we need a broad portfolio of vaccines based on very different technologies". (Photo by Thierry Monasse/Getty Images)